This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Paloma Giangrande
Director of Research at Moderna Therapeutics


Dr. Giangrande is an Associate Professor of Internal Medicine (U of Iowa) and a Director of Research (Moderna Therapeutics, Cambridge, MA). She obtained her BS in Biochemistry at Wheaton College in 1994 and her PhD in Pharmacology and Cancer Biology at Duke University in 1999. She is an internationally recognized expert in oligonucleotide therapeutics and delivery and was the first to demonstrate that RNA ligands (aptamers) can be used to deliver siRNAs to specific cell-types in vivo. Her career has been dedicated to the development of RNA-based therapeutic approaches (including aptamers, siRNAs, and mRNA) for cancer, cardiovascular disease, rare diseases, and critical illness. Her contributions to the field have been recognized with awards from several scientific societies. Her 60+ publications/9+ patents are a testament to her commitment to the development of novel RNA-based therapies for many diseases.

Agenda Sessions

  • mRNA Therapy for Inherited Disorders of Glycogen Metabolism


Speakers at this event